You're offline. Previously read public pages remain available; new requests will resume when you reconnect.
The news. The narrative. The timeline.
AP ties the deaths to Kennedy's vaccine rhetoric while X splits over causation, but both frames skip past the November vote that could strip the US of its measles-elimination status.
WHO's technical caveats bury a milestone X reported ten days early, and both sides underplay that the strain driving it has no licensed vaccine.
Yesterday's obituary was about music and philanthropy in the abstract; today's science press reframes her as a specific research funder who helped seed a COVID vaccine years before anyone needed one.
MSM obituaries lead with auction records and billion-dollar market value; social discourse leads with the childhood hallucinations and voluntary hospitalization that produced the work in the first place.
The 'protects the heart and brain' framing is spreading online as settled fact; the study itself is an observational natural experiment whose own authors say it still needs a randomized trial to confirm.
The 1,357-device milestone gets covered as AI's arrival in medicine; the study behind it finds the regulatory pathway that produced it never required proof any device actually helps a patient.
MSM covers the story in acre-feet and percentages; none of that coverage — or the federal announcement itself — translates a 17 percent Nevada cut into what it costs an actual household or farm.
Headlines keep using 'vaccine deployment' language that implies an approved shot; WHO's own recommendations say plainly there is none, only trials in progress.
Trade coverage aims at benefits managers; the consequence for workers' premiums stays implicit even as the biggest employers admit they can't predict costs.
MSM frames it as risk-averse behavior; viral X statistics outrun what the peer-reviewed research actually measures.
MSM covers policy-adoption mechanics; whether the bans actually work remains the question both sides skip.
MSM runs it as an administration-credit story; harm-reduction accounts credit infrastructure that's simultaneously being defunded.
MSM covers the leadership reshuffle; the live sham-surgery ethics fight underneath gets buried.
MSM runs the Dolly-name-coincidence angle; the actual 60% development odds are the real story during peak season.
MSM covers it as a logistics milestone; X has spent weeks selling the dark-energy stakes MSM saves for launch day.